S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Alkermes Inc. plc

ALKS XNAS
$34.99 -0.41 (-1.16%) ▼ 15-min delayed
Open
$35.77
High
$35.93
Low
$34.87
Volume
2.62M
Market Cap
$5.83B

About Alkermes Inc. plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 2.0K Website →

Key Financials

Period Revenue Net Income EPS
Q1 2026 $392.91M $-66,480,000 $-0.40
FY 2025 $1.48B $241.66M $1.47
Q3 2025 $394.19M $82.76M $0.50
Q2 2025 $390.66M $87.10M $0.53

Related Market News

No specific coverage for ALKS yet. Check out our latest market news or earnings calendar.

Get ALKS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Alkermes Inc. plc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.